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In established obesity inflammation and macrophage recruitment likely contribute to 
the development of insulin resistance. In the present study, we set to explore whether 
adipose tissue infiltration by neutrophils that occurs early (3 days) after initiating 
high-fat diet (3dHFD) could contribute to the early occurrence of hepatic insulin 
resistance, and to determine the role of cytosolic phospholipaseA2α (cPLA2α) in this 
process. 3dHFD caused a significant upregulation of cPLA2α in peri-epididymal fat 
and in the liver. A specific antisense oligonucleotide (AS) effectively prevented 
cPLA2α induction, neutrophil infiltration into adipose tissue (likely involving MIP-2), 
and protected against 3dHFD-induced impairment in hepatic insulin signaling and 
glucose over-production from pyruvate. To sort out the role of adipose neutrophil 
infiltration independent of cPLA2α induction in the liver, mice were injected 
intraperitoneally with anti-ICAM-1 antibodies. This effectively prevented neutrophil 
infiltration without affecting cPLA2α or MIP-2, but like AS, prevented impairment in 
hepatic insulin signaling, the enhanced glucose-to-pyruvate flux, and the impaired 
insulin-mediated suppression of hepatic glucos  production (assessed by clamp), 
which were induced by 3dHFD. Adipose tissue secretion of TNFα was increased by 
3dHFD, but not if mice were treated with AS or ICAM-1 antibodies. Moreover, 
systemic TNFα neutralization prevented 3dHFD-induced hepatic insulin resistance, 
suggesting its mediatory role. We propose that an acute, cPLA2α−dependent, 
neutrophil-dominated inflammatory response of adipose tissue contributes to hepatic 
insulin resistance and glucose overproduction in the early adaptation to high-fat 
feeding.    
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INTRODUCTION  
Established obesity, particularly if associated with insulin resistance-related 
morbidities, is characterized by systemic and adipose tissue inflammation (1-3). The 
complexity of the adipo-cytokines and inflammatory cell types involved in adipose 
inflammation is constantly increasing, and today most myeloid cell types have been 
implicated in the process, including macrophages, B-cells, various T-lymphocyte 
classes and even eosinophils and mast cells (4-6). In contrast to the above, much less 
is known about adipose tissue and liver adaptation to short-term high fat diet, before 
overt obesity is present. Metabolically, it appears that hepatic insulin resistance may 
be a front-line response to short-term (3 days) high-fat diet (3dHFD) (7; 8), 
representing either "physiological adaptation" and/or an early mal-adaptive response 
on the causal pathway to obesity-induced whole-body insulin resistance. It currently 
remains unclear to what degree this early response to HFD involves immune cells in 
general, and specifically in adipose tissue. 
 In a previous study we have demonstrated that during the first week of 
initiating HFD, adipose tissue is infiltrated by neutrophils (9). Adipose tissue protein 
levels of the neutrophil-specific myeloperoxidase were increased, and 
correspondingly, by histology an increased number of neutrophils was detected 
within the parenchyma of adipose tissue (i.e., not restricted to blood vessels). This 
early appearance of neutrophils in adipose tissue was recently confirmed (10), 
suggesting that adipose tissue inflammation in obesity largely follows the classical 
inflammation paradigms of acute versus chronic inflammatory cell infiltrates, 
predominated first by neutrophils, then lymphocytes in the sub-acute period, and 
finally by mononuclear macrophages, when inflammation becomes chronic. Yet, the 
co-occurrence of increased adipose neutrophil infiltration (9; 10) with the early 
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hepatic insulin resistance (7; 8) begs the question of whether the former phenomenon 
is causative for the latter. 
Cytosolic phospholipase A2α (cPLA2α) has received much attention as a key 
regulator of inflammation. It plays a major role in stimulus-initiated production of 
eicosanoids (prostaglandins and the chemoattractant leukotrienes) and platelet 
activating factor (11). In a previous study we demonstrated that cPLA2α is 
upregulated  in vascular endothelial cells in adipose tissue of mice in response to 
3dHFD and that it mediates the elevated expression of the endothelial adhesion 
molecule ICAM-1 (12) that is utilized for adhesion by neutrophils and monocytes. In 
addition, cPLA2α has been demonstrated to regulate superoxide generation by 
NADPH oxidase activation (13), thus promoting phagocyte-induced oxidative stress. 
Intriguingly, in humans, even a single exposure to high-fat containing meal induced 
NADPH activation and inflammatory cascades in circulating leucocytes (14-16). 
These findings suggest that cPLA2α could participate in priming/activation of 
circulating cells upstream in inflammatory cascades that ultimately lead to adipose 
tissue infiltration by neutrophils, way before obesity has developed. In the present 
study we set up to reveal the role of cPLA2α and adipose tissue neutrophil infiltration 
in the acute adaptation to 3dHFD, with emphasis on whether these early inflammatory 
responses could underlie the development of hepatic insulin resistance.  
 
RESEARCH DESIGN AND METHODS  
Animals and diets.  The study was approved by Ben-Gurion University Institutional  
Animal Care and Use Committee (IL-35-2006), and was conducted according to the 
Israeli Animal Welfare Act following the guidelines of the Guide for Care  
and Use of Laboratory Animal (National Research Council, 1996). Male C57BL/6J 
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mice (Jackson, Maine USA) at 6 weeks of age were fed either a low fat diet (LFD; 6% 
calories from fat; Harlan Teklad 2018sc) or a high fat diet (60% calories from fat; 
Research diets #12492), as previously performed (17). At the indicated times mice 
were euthanized by CO2 and peri-epdidymal fat was dissected out, and immediately 
fixed in 4% formaldehyde, or snap-frozen and stored in liquid nitrogen until further 
analyzed. A combination of two oligonucleotides antisenses (tcaaaggtctcattccaca, 
gctgtcaggggttgtag) and their corresponding senses with phosphorothioate 
modifications on the last 3 bases at both 5’ and 3’ ends was used as described 
previously (18).  For insulin stimulation, insulin was administered intravenously 5 
min prior to killing the mice, and livers or epididymal fat pads were immediately 
obtained and flash-frozen until analysis. Insulin doses of 0.5 and 2 U/kg gave 
identical signaling responses.  LEAFTM purified anti-mouse Ly-6G antibodies, 
LEAFTM purified anti-mouse TNFα antibodies (MP6-XT22), LEAFTM purified anti-
mouse CD54 antibodies and their isotype control IgG antibodies (BioLegend, San 
Diego, CA) were used for neutrophils depletion,  TNFα neutralization and ICAM-1 
neutralization, respectively.   
 
Immunoblot analysis.   Epididymal fat were lysed in ice-cold lysis buffer exactly  as 
done earlier (9). Samples were subjected to 7.5% SDS-polyacrylamide gel 
electrophoresis (for each sample 100 µg). The resolved proteins were 
electrophoretically transferred onto a nitrocellulose membrane, blocked in 5% milk in 
TBS-T (TBS containing 0.1% Tween-20), and incubated overnight at 4ºC with either 
goat anti- mouse myeloperoxidase (MPO) (1:100) (Santa Cruz, CA), anti mouse 
β−actin (1:10,000), anti-pSer473 Akt (1:1000), anti-Akt (1:1000), anti-pSer9 GSK 
(1:1000), anti-GSK (1:1000) anti cPLA2α(1:200) (Cell signaling, Beverly, MA), anti 
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5-lipoxygenase (5-LOX) (1:1000) (Cayman, Ann Arbor, USA)  anti Cyclogenase-2 
(COX-2) (1:1000) (Abcam, Cambridge, UK).  After being washed with TBS-T (four 
washes for 15 min each) the membranes were incubated with 1:10,000 dilutions of the 
respective HRP-conjugated secondary antibodies for 1.5 hr at room temperature and 
proteins were quantified using video densitometry analysis (ImageGauge version 4.0 
Fuji) as described previously (19; 20).  
 
Preparation of neutrophils. Heart blood was withdrawn before sacrifice. 
Neutrophils, at 95% purity, were obtained by Ficoll-Hypaque centrifugation, dextran 
sedimentation, and hypotonic lysis of erythrocytes.  Cells were counted and their 
viability was determined by trypan blue exclusion. 
 
Immunohistochemistry for neutrophil detection -  Epididymal fat tissues were 
embedded in paraffin and sectioned using a Leica microtome (Agentek, Canada). 
Neutrophil staining by rat anti-mouse monoclonal anti-NIMP-R14 antibody to 
identify  neutrophils (Novus Biological Inc.) was analyzed as done before (9; 13) 
based on an earlier study (21). Nonspecific reactivity was blocked by incubating the 
slides with 20% normal rabbit serum for 20 min (avidin-biotin VECTA-STAIN Kit 
Elite PK 6105; Vector Laboratories, Burlingame CA). Sections were then incubated 
in 1:10 dilution of anti-NIMP-R14 antibodies in PBS for 1 hr at room temperature, 
washed, and further incubated with 1:200 dilution of biotinylated anti-rat IgG, 
followed by avidin-biotin complex/HRP –DAB, which resulted in brown staining of 
neutrophils. For each treatment a negative control was prepared without the primary 
antibody. The sections were counter-stained with hematoxylin and analyzed in a 
blinded fashion using an Olympus BX-60 microscope.  
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Superoxide generation. The production of the superoxide anion by intact neutrophils 
was measured as the superoxide dismutase inhibitable reduction of acetyl 
ferricytochrome c by the microtiter plate technique as previously described (22).   
 
Cytokines and eicosanoids release measurements.  Epididymal fat tissue from mice 
were removed, weight, sliced and incubated for 3 hours in 1 ml medium containing 
0.1%BSA. The collected media were measured using commercial ELISA kits for: 
TNFα (Biolegend, San Diego, CA, USA) 15 µg tissue for each sample, MIP-2, KC, 
LTB4 , IL-6 (all from R&D systems, Inc. Minneapolis, MN, USA) 150 µg tissue  for 
each sample.  PGE2 levels were determined according to a dextran coated charcoal 
radioimmunoassay protocol, using  PGE2 standard, anti-PGE2 anti-serum (Sigma 
Israel, Rehovot, Israel) and [3H]PGE2 (Amersham Biosciences, NJ, USA) exactly as 
previously described (23).  
 
Pyruvate tolerance test (PTT).  PTT was performed by intra-peritoneal injection of 
2 g/kg body weight pyruvate in saline after an overnight fast. Blood glucose 
concentrations were measured via tail bleed before and at times indicated after 
injection (24) . All glucose measurements were made using a glucometer (Abbott, 
Alameda, CA).  
 
Homeostasis model index of insulin resistance (HOMA-IR) - was  calculated by 
multiplying fasting plasma insulin concentration (mU/L) with fasting plasma glucose 
(mmol/l) divided by 22.5 (25-27). Plasma insulin levels were determined by ELISA 
(ALPCO Diagnostics, Salem, NH, USA) 
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Glucose clamp studies.  Glucose clamp studies in freely moving mice were 
performed as described  (28). Steady-state glucose infusion rate was calculated once 
glucose infusion reached a near-constant rate to maintain glucose at 5 mmol/l for 20 
min.The glucose disposal rate was calculated by dividing the rate of [3-3H]glucose 
infusion by the plasma [3-3H]glucose specific activity (29; 30). Endogenous glucose 
production during the clamp was calculated by subtracting the glucose infusion rate 
from the glucose disposal rate (29; 30). Insulin-stimulated glucose disposal rate was 
calculated by subtracting basal endogenous glucose production (equal to basal glucose 
disposal rate) from glucose disposal rate during the clamp (31). 
 
Statistical analysis. Data are presented as the mean± SEM. Statistical significance for 
comparison between two groups was determined using Student’s paired two-tailed t 
test, and for >2 treatment groups by ANOVA followed by Bonferroni correction or by 
Newman-Keuls post-hoc test  GraphPad Prism version 5.03. 
 
 
 
 
RESULTS 
The time-course of development of insulin resistance in response to HFD was 
determined in liver and in peri-epididymal fat pads by assessing insulin-stimulated 
phosphorylation of Akt. At different times after initiating HFD, insulin was 
intravenously injected to the mice 5 min before harvesting livers. Three days after 
initiating HFD, hepatic insulin-stimulated Ser473-Akt phosphorylation was markedly 
attenuated (Figure 1A). At this time-point of marked diminution of insulin signaling 
in the liver, adipose tissue exhibited a normal insulin-stimulated Ser473-Akt 
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phosphorylation (Figure 1B). Insulin resistance in this tissue required a longer 
duration of HFD to manifest (not shown). Nevertheless, 3dHFD was already 
sufficient to induce a statistically significant increase in adipose tissue weight (Figure 
1C) and a notable increase in adipocyte cell size (Figure 1D). As reported in a 
previous study (9) multiple neutrophils were visible between adipocytes, indicating  
infiltration of the tissue parenchyma. (Figure 1D). Concomitantly, by histology, 
hepatic lipid content was notably mildly increased in mice on 3dHFD (Figure 1E), as 
were fasting glucose levels (Table 1). Calculated HOMA-IR values revealed systemic 
insulin resistance induced by 3dHFD (Table 1).  
We hypothesized that adipose tissue neutrophil infiltration induced by 3 days 
of  HFD (9) could participate in the early induction of hepatic insulin resistance. To 
test this hypothesis, adipose neutrophil recruitment was first prevented using oligo-
antisense against cPLA2α (AS). This approach was based on previous findings 
demonstrating: i. the effectiveness of AS administration in inhibiting neutrophil 
recruitment to the site of inflammation (13);  ii. that 3dHFD induces cPLA2α up-
regulation in adipose tissue (12). One mg/kg AS, 1 mg/kg corresponding (control) 
sense oligonucleotide, or saline, were intravenously injected to the tail vein of mice 
one day prior to, and then daily during the 3dHFD. Weight gain was not affected by 
either AS or sense treatments (Figure 2A), but AS treatment significantly prevented 
the elevated cPLA2α protein expression detected in lysates of adipose tissue of 
3dHFD mice (Figure 2B). The AS treatment also significantly prevented the 
recruitment of neutrophils to the adipose tissue of mice on HFD, as detected by 
adipose protein levels of MPO (Figure 2C) and by quantitation of neutrophils by 
NIMP-R14 immunostaining (Figure 2D). To analyze whether AS protected against 
hepatic insulin resistance, insulin  induction of liver phospho-Ser473-Akt or phospho-
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Ser9-GSK3β was assessed (32; 33). AS, but not sense treatment,  prevented HFD-
induced impairment of insulin-stimulated Akt and GSK-3β phosphorylation (Figures 
2E, 2F), without affecting liver histology (not shown). AS treatment  did not affect the 
normal insulin signaling in the adipose tissue (not shown). At the whole-body 
metabolic level, 3dHFD was associated with an exaggerated glucose production 
during a pyruvate tolerance test as compared to LFD mice, and this enhanced 
pyruvate-to-glucose flux was prevented by AS as compared to the sense-treated mice 
(Figure 2G). Liver cPLA2α was also upregulated by 3dHFD, and like in adipose 
tissue this increased expression was prevented by AS treatment (Figure 3A). 
However, neutrophils infiltration to adipose tissue seemed to constitute a unique 
response of this tissue to 3dHFD, as there was no similar elevation in the levels of the 
neutrophil-selective protein MPO in the liver (Figure 3B).  Thus, AS directed against 
cPLA2α decreased the elevated expression of this phospholipase in both adipose 
tissue and the liver, and concomitantly prevented the tissue-selective neutrophil 
infiltration into adipose tissue, which were induced by 3dHFD. These effects were 
associated with prevention of impaired hepatic insulin signaling and enhanced 
pyruvate-to-glucose flux that developed during early adaptation to HFD.  
To further support the role of neutrophil recruitment to adipose tissue in 
inducing liver insulin resistance, and to differentiate its effect from the possible 
consequences of increased expression of cPLA2α in the liver, neutrophil recruitment 
was prevented using anti ICAM-1 antibodies. Mice were injected intra-peritoneally 
with 100 µg anti-mouse ICAM-1 antibodies or isotype control IgG antibodies every 
other day beginning 2 days prior to initiating HFD. Treatment with anti ICAM-1 
antibodies, but not with control IgG antibodies, reduced MPO expression in adipose 
tissue (Figure 4A) and the number of neutrophils as analyzed histologically by NIMP-
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R14 (from 11.56+1.2  to 3.49+0.9 neutrophils per high power field, p<0.001), 
indicating the prevention of adipose neutrophil recruitment, without affecting body 
weight  (Figure 4B). Importantly, this approach to prevent HFD-induced adipose 
neutrophil infiltration did not attenuate the diet-induced elevation in cPLA2α protein 
expression in the liver (Figure 4C). Inhibition of neutrophil infiltration to adipose 
tissue significantly improved hepatic insulin signaling, as detected by insulin-
stimulated p-Akt and p-GSK (Figure 4D, E) without affecting liver histology (not 
shown) or adipose insulin signaling (not shown), and consistently, alleviated the 
augmented gluconeogenic flux from pyruvate induced by 3dHFD (Figure 4F). To 
further confirm that prevention of adipose infiltration by neutrophils improved hepatic 
insulin sensitivity, hyperinsulinemic-euglycemic clamp studies were conducted. 
Glucose infusion rate was significantly decreased in HFD-fed mice (Fig. 4G and 
Suppl. Fig. 1). However, no difference was observed between IgG- and ICAM-treated 
mice (Fig. 4G and Suppl. Fig. 1). Insulin-mediated inhibition of endogenous (mainly 
reflecting hepatic) glucose production was significantly reduced in IgG-treated HFD-
fed mice (Fig. 4H). In contrast, ICAM-treated HFD-fed mice showed a conserved 
response to insulin suggesting improved hepatic insulin sensitivity in ICAM-treated 
compared to IgG-treated HFD-fed mice (Fig. 4H). Of note, three days of HFD did not 
significantly impact insulin-stimulated glucose disposal rate (mainly reflecting 
skeletal muscle insulin sensitivity) although a slight decrease in the anti-ICAM-1-
treated group was apparent (Figure 4I). High variability in insulin-stimulated glucose 
disposal rate may have prevented a significant difference in GIR between the two 
HFD-fed groups (Fig. 4G). These hyperinsulinemic-euglycemic clamp results are 
consistent with a state of selective hepatic insulin resistance induced by 3dHFD, 
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which can be alleviated by anti-ICAM-1 antibodies that prevent adipose tissue 
neutrophil infiltration.  
  To gain further support for the role of adipose neutrophil infiltration in the 
induction of hepatic insulin resistance, neutrophil infiltration was prevented by an 
alternative approach, i.e., by neutrophil depletion using Ly6G-specific monoclonal 
antibody, as described (34; 35). Mice were injected intra-peritoneally with 150 µg 
anti-mouse Ly-6G antibodies or isotype control IgG antibodies one day prior to 
initiating 3dHFD. Neutrophil depletion was validated by FACS analysis using rat 
anti-mouse neutrophils antibodies (MCA771F, Serotec), as performed in a previous 
study (13). Neutrophil depletion significantly improved hepatic insulin 
responsiveness, as detected by insulin-stimulated p-Akt (Figure 4J) and p-GSK 
(Figure 4K). Collectively, inhibiting adipose neutrophil infiltration, independent of 
attenuating cPLA2α induction early after initiating HFD, prevented the early diet-
induced hepatic insulin resistance and glucose over-production.  
       We next assessed possible mechanisms related to: i. neutrophils' adaptation to 
HFD and to their recruitment to adipose tissue;  ii. the induction of hepatic insulin 
resistance in this specific model of short-term hyper-nutrition.  Neutrophils' tissue 
infiltration is a process associated with cellular activation and with specific 
chemoattractants that direct these cells to the site of inflammation. Indeed, peripheral 
blood neutrophils from mice on 3dHFD released significantly higher levels of 
superoxides (Figure 5A), suggesting that neutrophil activation is induced by the diet. 
Consistent with our previous report (13), the AS treatment attenuated the release of 
superoxides. Several putative adipose tissue-derived neutrophil chemoattractants are 
known as potent activators. These factors include the cPLA2-dependent metabolite 
LTB4, previously shown by us to recruit neutrophils to the peritoneal cavity of a 
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mouse model of sterile peritonitis (13), and the neutrophil-selective chemoattractant 
IL-8. The IL-8 ortholog in mice is keratinocyte chemoattractant (KC or CXCL1), and 
MIP-2 (CXCL2), both ligands for the chemokine receptor, CXCR2 (36). Epididymal 
fat tissue from 3dHFD-fed mice and control (3dLFD) mice expressed similar levels of 
5-LOX protein and released similar levels of LTB4, with no effect on these parameters 
by AS treatment (Figure 5B,5C). Similarly, secretion of the neutrophil 
chemoattractant KC was not affect by 3dHFD or by the AS treatment (Fig. 5D). Yet, a 
significantly increased secretion of MIP-2 from adipose tissue of mice on 3dHFD was 
detected (Figure 5E, 5F). AS-treated 3dHFD mice secreted significantly lower levels 
of MIP-2, similar to those of the control mice (Fig 5E), suggesting that cPLA2α is 
involved in regulation of MIP-2 production. In contrast, treatment of 3dHFD mice 
with anti ICAM-1 antibodies did not attenuate MIP-2 secretion (Figure 5F), 
suggesting that cPLA2α upregulation, but not the consequential neutrophil infiltration, 
are involved in adipose tissue MIP-2 production. Jointly these findings suggests a 
putative role for adipose MIP-2 as a chemoattractant involved in neutrophil 
recruitment to the epididymal fat tissue early after initiating HFD.  
In order to shed light on the mechanisms by which neutrophil infiltration to 
adipose tissue might induce hepatic insulin resistance, we determined if 
secretion/expression of PGE2, COX2, and the pro-inflammatory cytokines IL-6 and 
TNFα are increased already 3 days after initiating HFD. Both cPLA2α and COX2 are 
robustly increased in various tissues during active inflammatory processes, and PGE2, 
the metabolite of arachidonic acid, has been recently implicated in insulin resistance 
(37). Yet, no increase in either COX2 expression or PGE2 secretion from adipose 
tissue was observed in 3dHFD compared with control mice (Figures 6A,6B, 
respectively). There was also no increase in the secretion of IL-6 (Figure 6C), but 
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TNFα (Figure 6D,6E) was significantly elevated in adipose tissue of mice on HFD, an 
effect of the diet, prevented by either AS or anit-ICAM-1 antibodies. To further 
establish the mediatory role of TNFα in hepatic insulin resistance following 3dHFD, 
TNFα was neutralized, using anti-mouse IgG1 monoclonal antibody, as in (38). Mice 
were injected intra-peritoneally with 150 µg anti-mouse TNFα antibodies or isotype 
control IgG1 antibodies, 1 day prior to initiating HFD and at day 2 of HFD. The 
elevated  serum TNFα levels in HFD mice (8.7+0.9 pg/ml  compared with 5.5+0.7 in 
LFD mice) was significantly (p<0.001) reduced by anti TNFα antibodies treatment 
(4.5+0.6 pg/ml), but not by control IgG1 antibodies (8.1+0.7 pg/ml).   Serum TNFα 
neutralization significantly improved hepatic insulin responsiveness, as detected by 
insulin-stimulated p-Akt and p-GSK (Figure 6F, 6G.) 
 
 
DISCUSSION 
The present study shows that hepatic insulin resistance induced by short-term 
HFD reflects dys-regulated adipose-to-liver axis that is initiated by a cPLA2α-
mediated, neutrophil-predominated, adipose tissue inflammation. Our studies reveal 
that: i. Hepatic insulin resistance develops as early as 3 days after initiating HFD, 
consistent with recently published studies (7; 8);  ii. Neutrophils recruitment to 
adipose tissue is critical for the induction of hepatic insulin resistance in response to 
3dHFD. Increased adipose tissue TNFα secretion may constitute a mediator in this 
response, since both increased TNFα secretion and hepatic insulin resistance were 
prevented when neutrophil infiltration was attenuated, and neutralizing TNFα  
significantly prevented hepatic insulin resistance.  iii. The recruitment of neutrophils 
to adipose tissue likely involves cPLA2α-dependent MIP-2 secretion.  
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Consistent with both our previous (9) and present studies, recruitment of 
neutrophils to adipose tissue following 3 days of HFD was recently confirmed by 
others (10),  and  the role of adipose tissue neutrophils in insulin resistance was also 
demonstrated. Adipose tissue recruitment of neutrophils is also consistent with a study 
demonstrating increased leukocyte-endothelial cells-platelet interaction in the 
microcirculation of visceral adipose tissue in obesity (39). Moreover, in humans, 
pregnant obese women with preeclampsia exhibited extensive vascular inflammation 
characterized predominantly by neutrophils, demonstrable in adipose tissue blood 
vessels (40). The present study, however, offers several novel observations and 
mechanistic insights: 3dHFD constitutes a unique state predominantly affecting 
hepatic insulin responsiveness, independent of skeletal muscle and/or adipose tissue 
insulin resistance that apparently take longer to develop. Under such conditions of 
"isolated hepatic insulin resistance", we were able to demonstrate that neutrophil 
recruitment, specifically to adipose tissue (and not to the liver), are necessary for 
hepatic insulin resistance to develop. Moreover, induction of adipose cPLA2α up-
regulation is deemed necessary for adipose tissue neutrophil infiltration, and is 
upstream of an inflammatory pathway involving the up-regulation of the neutrophil 
chemoattractant MIP-2, the up-regulation of the endothelial adhesion molecule 
ICAM-1 (12), and the adipose tissue neutrophils-dependent increased production of 
TNFα. Importantly, although cPLA2α is up-regulated also in the liver (as was 
neutrophil elastase in a recent study (10)), our results assign a role specifically for 
adipose, and not hepatic, cPLA2α up-regulation in the induction of hepatic insulin 
resistance and glucose over-production: By antagonizing ICAM-1, 3dHFD-induced 
increase in cPLA2α was still present, but adipose tissue neutrophil infiltration 
prevented, and hepatic insulin resistance was still averted. Thus, we provide 
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compelling evidence that adipose cPLA2α-mediated neutrophil infiltration, 
specifically to adipose tissue, contributes to hepatic insulin resistance in response to 
acute short-term high fat feeding. It may be speculated that this early inflammatory 
response to a high-fat containing diet, consistent with studies in human circulating 
leucocytes (14-16), represents, at least in the short term, a physiological adaptation: 
isolated hepatic insulin resistance with preserved adipose tissue insulin sensitivity 
would assist in directing more storage of excess calories in adipose tissue, and less in 
ectopic sites.     
Recruitment of different immune cell types to adipose tissue and consequential 
changes in cytokines secretion have been documented during the last years, mainly at 
much later time points of diet-induced obesity. These include CD11c+, M1-like 
macrophages (2; 4; 41; 42) and  B and CD8+ T-lymphocytes (43-45).  However, the 
recruitment of lymphocytes to adipose tissue was not directly linked with induction of 
insulin resistance (5). Although Kupffer cells were proposed to mediate the induction 
of hepatic insulin resistance by 3dHFD (7), another study reported opposite results (8) 
suggested that while macrophage-mediated tissue inflammation is a key component of 
chronic obesity–associated insulin resistance, it is not critical for the decrease in 
insulin sensitivity - at the early adaptation to HFD feeding. We therefore propose that 
most likely, in the acute response to HFD, neutrophils may well constitute the major 
driver of adipose tissue inflammation and hepatic insulin resistance. 
cPLA2α was recently suggested to be involved in the storage of lipids in the 
adipose tissue and liver during prolonged obesity (46) and in 3T3-L1 cells (47). In the 
present study prevention of cPLA2α up-regulation by AS treatment in mice on 
3dHFD did not interfere with weight gain. Thus, cPLA2α regulates the adaptation to 
3dHFD independent of weight gain or adipocyte hypertrophy. The results of the 
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present study suggest that MIP-2, a mouse ortholog of human IL-8, signals 
neutrophils recruitment downstream of cPLA2α (Fig. 6). This observation may be also 
highly relevant for humans in which adipose tissue IL-8 levels were elevated  (48-50). 
MIP-2 has been shown to be one of the major inducible chemokines with the ability to 
attract neutrophils to the site of inflammation (51). KC and MIP-2 have temporally 
distinct patterns of expression and cell type-specificity (52). MIP-2 was shown to be 
produced by resident macrophages and by neutrophils (36; 51). Therefore in response 
to 3dHFD MIP-2 is likely produced by resident macrophages and not by neutrophils, 
since MIP-2 production was reduced only with the AS treatment and not with anti-
ICAM-1 antibodies treatment, while in both treatments the recruitment of neutrophils 
to the adipose fat was prevented. As MIP-2 synthesis is TLR-dependent (36) and  
saturated FFAs act as a naturally occurring ligands of macrophage TLR4 (53), it is 
possible that elevation of FFA in the intra-abdominal adipose tissue by 3dHFD 
triggers the production of cPLA2α-dependent MIP-2 in resident macrophages, leading 
to neutrophils recruitment. Thus, cPLA2α facilitates neutrophil recruitment by two 
important steps of the process; the secretion of chemoattractant MIP-2 and the 
production of the adhesion molecule ICAM-1(12).    
We show here that circulating neutrophils are activated in mice on 3dHFD, as 
shown by the release of superoxides (Fig. 5A). This is consistent with the immediate 
activation of circulating neutrophils, the release of superoxides, increased expression 
of NADPH oxidase, and the increased proinflammatory cytokines demonstrated in 
healthy human subjects exposed to high fat and carbohydrate meal or during a glucose 
challenge (14-16; 54-57). The activated adipose neutrophil-produced factors that 
mediate hepatic insulin resistance have yet to be identified. Although neutrophil 
elastase is a likely candidate (10), it should be remembered that this was demonstrated 
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at 12 weeks of HFD, when its expression was also elevated in the liver. LTB4 or 
PGE2 were shown to impair insulin signaling (37; 58) and it was recently reported that 
adipose tissue LTB4 secretion contributes to elevation of adipose macrophages and T 
cells at 15 weeks of HFD (59) . Yet, they are unlikely to be involved in the response 
to 3dHFD.  Elevated local and circulating levels of TNFα and IL- 6 are known to be 
associated with obesity in both humans and rodent models (60-62) and both cytokines 
have been shown to induce hepatic insulin resistance (63; 64). While there was no 
increase in adipose secretion of IL-6 at 3dHFD, here we show that adipose tissue 
released significantly higher levels of TNFα , and that prevention of neutrophils 
infiltration to adipose tissue significantly attenuated this response.  TNFα blood levels 
were significantly elevated by short term HFD, consistent with a recent study  (8), and 
neutralizing these elevated TNFα levels prevented the development of hepatic insulin 
resistance by 3dHFD, further supporting its causal role in the process.  In accordance 
with our results, a much higher increase in TNFα than in IL-6 gene expression in 
adipose tissue at day 3 of HFD was reported (8). Thus, we propose TNFα as a 
potential mediator of primed adipose tissue neutrophils in causing hepatic insulin 
resistance induced by 3dHFD. 
In conclusion, we show here that adipose cPLA2α has a profound role in 
initiating hepatic insulin resistance during early response to hyper-nutrition. Adipose 
cPLA2α has a major role in promoting infiltration of activated neutrophils to adipose 
tissue in short-term HFD probably by increasing the production of the neutrophil 
chemoattractant MIP-2 and up-regulating ICAM-1. The presence of neutrophils in the 
adipose tissue induces elevated secretion of TNFα, which likely contributes to the 
early development of isolated hepatic insulin resistance.    
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Legend to Figures 
Figure 1: Short term HFD induces liver, but not adipose tissue insulin resistance.  
A.  Liver insulin resistance was determined by impaired insulin-stimulated phoshpo-
Akt on serine 473 (p-Akt) after i.v. injection of insulin.  Representative immunoblot 
of p-Akt  in liver lysates from mice at day 0 up to day 28 on HFD compared with liver 
lysates of a mouse that was not treated with insulin (-). After densitometry analysis, 
the ratio of the intensity of the p-Akt band to total Akt (t-Akt) was calculated and 
presented, as arbitrary units, by the mean ± SEM of 10 mice studied in 3 independent 
experiments. B. Normal insulin signaling in epididymal fat of 3dHFD mice.  A 
representative immunoblot of p-Akt in epididymal fat tissue lysates from mice on  HFD, 
control mice on LFD at day 3 and mice on day 0. Densitometry analysis were 
performed as in A. Results are mean ± SEM of 15 mice studied in 5 independent 
experiments.   C.  Epididymal fat mass of 10 mice on HFD and 10 mice on LFD at 
day 3 of the diet show a significant difference - *p<0.001 between the groups. Results 
are mean ± SEM of 2 different experiments. D.E. Histological sections of epididymal 
adipose tissues and immunolocalization of neutrophils (shown by arrows) using anti-
NIMP-R14 antibodies and hematoxylin counter-stating (amplification magnitude X 
400).  (D.) Histological sections of liver stained by H&E  (amplification magnitude X 
200) (E.) Shown are representative images of 10 mice in each group.  
 
Figure 2. Inhibition of neutrophils recruitment to epididymal adipose tissue by 
cPLA2α-specific antisense oligonucleotide prevents hepatic insulin resistance 
Mice were i.v. injected 1 day prior to the initiation of HFD and everyday during the 
diet with (2mg/kg) antisenses against cPLA2α(AS). The HFD control mice were 
administrated with either 100 µl saline or 2mg/kg sense (SE) oligonucleotide, and 
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since there was no difference between the two groups they were combined (SE).  
Control LFD mice were fed with normal diet for 3 days. Half of the control LFD mice 
were administrated with 100 µl saline that did not cause any effect compared with the 
non-injected nice. The weight and the densitometry of the immunoblot of the 
individual mice in each group performed in three independent experiments are 
presented.  
A. *p<0.001 between the two groups of mice on HFD and the group of mice on LFD 
at day 3 of the diet.  B. A representative immunoblot of cPLA2α and the 
corresponding β-actin protein expression in epididymal adipose tissue lysates of the 
different groups of mice.  The intensity of each cPLA2α band was divided by the 
intensity of the respective β-actin band after quantitation by densitometry, and 
expressed as arbitrary units. * p< 0.001 of control HFD mice (SE) in comparison to 
HFD mice with AS treatment or  LFD mice. C. A representative immunoblot and 
densitometry analyses of MPO (a specific neutrophil marker) and β-actin in  
epididymal fat from LFD mice, AS treated HFD mice and control mice (SE). The 
intensity of each MPO band was divided by the intensity of the respective β-actin 
band after quantitation by densitometry, and expressed as arbitrary units.  * p< 0.001 
in  control  HFD  mice  (SE) in  comparison to AS treated HFD mice or  LFD mice. 
D. The presence of stained neutrophils using mouse anti-neutrophils antibody (NIMP-
R14) in sections of epididymal adipose tissues.  Results are the mean±SEM number 
per filed, derived from 20 individual fields for each mice from 2 independent 
experiments. * p< 0.001 in control HFD mice (SE) in comparison to AS treated HFD 
mice or  LFD mice. E.F.  For each group of mice, liver lysate of a mouse that was not 
treated with insulin (-) and lysates from two different mice treated with insulin (+) are 
presented.  Densitometry analysis for p-Akt and p-GSK were preformed as in Fig. 1A. 
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* p< 0.001- significant decrease of control HFD mice (SE) in comparison to HFD 
mice with AS treatment or  LFD mice.   G. Pyruvate tolerance test after overnight fast 
3dHFD mice. The results are the mean+SEM of 6 mice in each group performed in 
two independent experiments. The inset describes the area under the curve (AUC).     
* p<0.05, ** p< 0.01,  compared to SE-treated HFD mice (SE) by two-way ANOVA 
and Bonferroni’s post test analysis.   
 
Figure 3: The effect of cPLA2α AS treatment in livers of HFD mice 
A. A representative immunoblot analysis of cPLA2α and the corresponding β-actin 
protein expression in liver lysates of the different groups of mice. Densitometry 
analysis for cPLA2α was preformed as in Fig. 2B. * p< 0.001- significant increase of 
control HFD mice (SE) in comparison to HFD mice with AS treatment or  LFD mice.   
B. A representative immunoblot of MPO in liver of LFD mice, control HFD mice 
(SE) and AS treated HFD mice.  Densitometry analysis for MPO was preformed as in 
Fig. 2C.  There are no differences between the various groups of mice.  
 
Figure 4:  Prevention of neutrophil recruitment to epididymal adipose tissue by 
anti-ICAM-1 antibodies prevented hepatic insulin resistance in response to 
3dHFD 
Mice were i.p.. injected (100µg/kg) anti-ICAM-1 antibodies 2 days prior to the 
initiation of HFD and every other day thereafter. The HFD control mice were 
administrated with either 100 µl saline or rat IgG2b, isotype control. The weight and 
the densitometry of the immunoblot of the individual mice in each group performed in 
three different experiments are presented.   
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A. A representative immunoblot of MPO in epididymal fat. Densitometry analysis for 
MPO was performed as described in Fig. 2C.  * p< 0.001.- Significant increase of 
control HFD mice and anti IgG treated HFD mice  in comparison to HFD mice treated 
with anti-ICAM-1 antibodies and LFD mice.  B. Effect of treatment on body weight.  
*p<0.001 between the groups of mice on HFD and the group of mice on LFD at day 3 
of the diet.    C. A representative immunoblot analysis of cPLA2α and the 
corresponding β-actin protein expression in adipose tissue lysates of the different 
groups of mice. Densitometry analysis for cPLA2α was preformed as in Fig. 2B. 
There is a significant difference *p<0.001 between the groups of mice on HFD 
compared with LFD at day 3 of the diet. D.E.  Representative immunoblots and 
densitometry analyses of phsopho-Akt (serine 473) and phosphor-GSK (serine 9).    
For each group of mice, liver lysate of a mouse that was not treated with insulin (-) 
and lysates from two different mice treated with insulin (+) are presented.  
Densitometry analysis for p-Akt and p-GSK were preformed as in Fig. 1A.                 
* p< 0.001.- Significant decrease of control HFD mice and anti IgG treated HFD mice  
in comparison to HFD mice  treated with anti-ICAM-1 antibodies and  LFD mice.        
F. Pyruvate tolerance test after an overnight fast. The inset describes the area under 
the curve (AUC). The results are the mean+SEM of 6 mice in each group performed 
in two independent experiments ** p<0.01, * p<0.05 compared to ICAM-1 antibody-
treated HFD mice by two-way ANOVA and Bonferroni’s post test analysis. G.H.I. 
Hyperinsulinemic-euglycemic clamp studies with (G) glucose infusion rate (GIR), 
and (H) insulin-inhibited endogenous glucose production (EGP) and (I) insulin-
stimulated glucose disposal rate were conducted in chow-fed (open), IgG-treated 
HFD-fed (grey) and ICAM-treated HFD-fed (black) mice. (Further clamp results are 
in supplemental data 1). Results are the means of 4 (chow-fed) or 4 (HFD-fed) 
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animals. All error bars represent SEM. *p < 0.05, **p < 0.01 ANOVA followed by 
Newman-Keuls post-hoc test.  J.K. Neutrophil depletion prevented insulin resistance 
in 3dHFD liver- Representative immunoblots and densitometry analyses of phsopho-
Akt (serine 473) and phosphor-GSK (serine 9).    For each group of mice, liver lysate 
of a mouse that was not treated with insulin (-) and lysates from two different mice 
treated with insulin (+) are presented.  Densitometry analysis for p-Akt and p-GSK 
were preformed as in Fig. 1A. * p< 0.001- Significant decrease of control HFD mice 
in comparison to neutrophil depleted HFD mice  and  LFD mice.  
 
Figure 5: Three days of high fat feeding peripheral blood neutrophil and adipose 
tissue release of MIP-2 
A. Spontaneous superoxide production by isolated peripheral blood neutrophils from 
individual HFD mice and LFD mice at day 3 of the diet performed in three different 
experiments is presented.  * p< 0.001- significant increase of control HFD mice (SE) 
in comparison to HFD mice with AS treatment or  LFD mice.  There are no 
differences between HFD mice with AS treatment and LFD mice.  
B.  A representative immunoblot of 5-LOX in epididymal fat lysates of LFD mice, 
control HFD mice (SE) and AS treated HFD mice.  Densitometry analysis were 
performed as for cPLA2α in Fig. 2A. Results are mean ± SEM of 12 mice.     C.D.  
LTB4 and KC release from adipose tissue explants of the different groups.   There are 
no significant differences between the groups.  E.  MIP-2 release from adipose tissue 
explants was significantly increased (* p< 0.001) in control HFD mice (SE) in 
comparison to HFD mice with AS treatment or LFD mice.   F. MIP-2 release from 
adipose tissue explants was significantly higher (*p<0.001) in the groups of mice on 
HFD compared with the group of mice on LFD at day 3 of the diet.  
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Figure 6 – TNFα is the possible adipose mediator for the induction of hepatic 
insulin resistance in response to short-term high fat diet.  
A. A representative immunoblot of COX-2 in adipose lysates of LFD mice, control 
HFD mice (SE) and AS treated HFD mice. Densitometry analysis were performed as 
for cPLA2α in Fig. 2A.  B.C. PGE2 and IL-6  release from adipose tissue explants.  
No statistically-significant differences between the groups were noted. D. TNFα 
release from adipose tissue explants was significantly increased (* p< 0.001) in 
control HFD mice (SE) in comparison to HFD mice with AS treatment or  LFD mice.  
E. TNFα release from adipose tissue explants was significantly increased (* p< 
0.001) in control HFD mice (SE) in comparison to HFD mice with AS treatment or  
LFD mice.   F.G.  TNFα neutralization prevented insulin resistance in 3dHFD liver - 
Representative immunoblots and densitometry analyses of phsopho-Akt (serine 473) 
and phospho-GSK (serine 9).    For each group of mice, liver lysate of a mouse that 
was not treated with insulin (-) and lysates from two different mice treated with 
insulin (+) are presented.  Densitometry analysis for p-Akt and p-GSK were 
preformed as in Fig. 1A. * p<0.001- Significant decrease of control and IgG treated 
HFD mice in comparison to TNFα depleted HFD mice or LFD mice.  
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Table 1  
 
Metabolic changes induced by 3-day HFD 
 
 
 
        LFD                      
 
      HFD 
3d body weight gain, g                                      0.28+0.09               2.28+0.11* 
Epididymal adipose tissue weight, g                0.17+ 0.01             0.26+0.01*   
Non-fasting serum insulin µg/l                         1.19+0.2                1.34+0.3        
Fasting blood glucose mg/dl                               110+9.1                 136+11.1** 
Fasting serum insulin µg/l                                0.31+0.03              0.36+0.04                            
HOMA-IR                                                            2.1+0.19                3.0+0.25**                                                                              
 
The results are mea + SEM of 10 mice in each group. Mice were fed a normal diet 
(LFD) or a high-fat diet for 3 days (HFD). *P <0.001 and **P< 0.05 in HFD 
compared with LFD. 
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Legends Supplement Figure 1 
Blood glucose concentrations, glucose infusion rates and plasma insulin levels during 
hyperinsulinemic-euglycemic clamp  (A) Blood glucose levels were clamped upon 
insulin infusion between 5 and 6 mmol/l. (B) In order to maintain euglycemia, 
glucose infusion rate was adjusted over time.  Chow-fed mice,  IgG-treated HFD-
fed mice,  ICAM-treated HFD-fed mice. n = 4.  
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